Janet Zeman serves as Executive at THERAGENICS CORP, where they oversee executive responsibilities. Since joining the company, Janet Zeman has executed 7 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 29, 2013 involved selling 235,962 shares valued at $519.1K.
Janet Zeman currently holds 235,962 shares of THERAGENICS CORP (TGX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Janet Zeman has been a net neutral trader of TGX stock. They have purchased $0 and sold $0 worth of shares.
Janet Zeman's most recent insider trade was on Oct 29, 2013, when they sold 235,962 shares at $2.20 per share.
Get notified when new Form 4 filings are submitted
| 68,182 |
| $2.20 |
| Discretionary |
| Feb 21, 2013 | TGX | $0 | Award | 128,000 | $N/A | Discretionary |
| Feb 24, 2012 | TGX | $0 | Award | 87,250 | $N/A | Discretionary |
| Feb 25, 2011 | TGX | $0 | Award | 30,600 | $N/A | Discretionary |
| Feb 25, 2010 | TGX | $0 | Award | 26,000 | $N/A | Discretionary |
| Feb 26, 2009 | TGX | $0 | Award | 15,000 | $N/A | Discretionary |